Blog
US FDA report finds economic forces at the root of generic antibiotic shortages
Generic antibiotics underpin recommended prescribing guidance for most infections, accounting for between 80% and 90% of prescriptions in primary healthcare worldwide. However, increasing costs and in...
Read more
The new reality for next-gen antibiotics
The future of antibiotic development lies in targeted approaches that can deliver novel drugs tailored to tackle those highly resistant pathogens with greatest medical need. The world of antibacte...
Read more
Putting the brakes on AMR in India
India’s ban on colistin in the animal food industry marks a critical move against AMR in the country; one that should go hand in hand with a stringent crackdown on inappropriate use in human medicin...
Read more
Overcoming Access Barriers to Antibiotics
Somewhat perversely, antibiotic overuse exists side-by-side with lack of access to such medicines in today’s world. While we are aware of the consequences of drug-resistant bacterial infections, it...
Read more
Creating new antimicrobial drugs will require governments working with industry
As the number of infections resistant to antimicrobial drugs continues to rise around the world, and with it their huge human and financial toll, we urgently need new ways to preserve the effectivenes...
Read more
By 2050, superbugs may cost the economy $100 trillion
This oped was first published in the Antimicrobial Resistance campaign in the Guardian on 12 November 2018. ANTIBIOTIC RESISTANCE Evidence suggests superbugs could cost the global economy up to 3....
Read more
Drugs companies are rising to the challenges of research into superbugs
This letter was first published on the Financial Times on 4th July 2018, in response to the article titled "Pharma sector failing to tackle superbugs, says O’Neill" (26th June 2018) I respectful...
Read more
Accelerating the development and delivery of new innovations for a TB-free world
Before the World Economic Forum, Davos’ first claim to fame was as a haven for wealthy tuberculosis sufferers in the 1800s and 1900s: the rarefied air of the Magic Mountain, as Thomas Mann dubbed it...
Read more
A Frightening Reality
From a sustainable antibiotics perspective, 2018 is not wasting time getting to the point. The new year has kicked off with tremendous momentum in the fight against antimicrobial resistance (AMR), wit...
Read more
Antimicrobial resistance is a growing health challenge
This blog was first published on NJToday on 5 February 2018. The growing global public health challenge of Antimicrobial Resistance (AMR) cannot be understated. By 2050, it is a predicted to acco...
Read more
Partnering to Combat Antimicrobial Resistance
This blog was first published on the author's LinkedIn page on 1 February 2018. Last week I had the chance to join in conversations on the current and future burden of antimicrobial resistance (AM...
Read more
Less talk, more action needed to avoid superbugs silent tsunami
This blog was first published on The Nation on 31 January 2018. On a TripAdvisor Bangkok forum Gary asks “Can I purchase antibiotics (in Thailand) without a prescription if I run out?”. rove...
Read more
Pulling Together To Thwart A Silent Killer
This blog was first published on Life Science Leader on 22 January 2018 As we start 2018, those of us in the healthcare sector are anticipating greater progress in global health. Without a doubt, h...
Read more
Stand and deliver – practical steps to stop antibiotic resistance
This blog was first published on Life Science Leader and Pharma Times on 14 November 2017. It is rapidly becoming the world’s biggest killer. Antimicrobial resistance (AMR) is on course to overta...
Read more
Defining standards & measures for AMR is the need of the hour
According to one of the report issued by some of the stakeholders last year, antibiotic industry or ingredient manufacturers were responsible for an estimated amount of 30,000-70,000 tons of anti-micr...
Read more
Unlikely bedfellows join to track efforts to fight superbugs
This blog was first published in thePharmaLetter on 30 May 2017. In January 2016, more than 100 companies and industry associations had signed a Declaration on Combatting Antimicrobial Resistanc...
Read more
B20 message to G20 – Health drives solutions built on collaboration and pro-innovation ecosystems
This blog was first published on G20 – The Hamburg Summit in July 2017 (Produced in association with the G7 and G20 Research Group at the University of Toronto) The fact that “health” has en...
Read more